Paper37856427
Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen.
Crawford CJ and 9 others. ACS Infect Dis, 2024. Cited by 14 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen. Papers, record 37856427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37856427
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cryptococcus neoformans | Major topic |
| Cryptococcosis | Major topic |
| Humans | |
| Antibodies, Fungal | |
| Epitopes | |
| Antibodies, Monoclonal | |
| Polysaccharides |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI052733 | NIAID NIH HHS | United States | R01AI052733 | PubMed and NIH | NIH RePORTER |
| R01 AI152078 | NIAID NIH HHS | United States | R01AI152078 | PubMed and NIH | NIH RePORTER |
| R01 AI162381 | NIAID NIH HHS | United States | R01AI162381 | PubMed and NIH | NIH RePORTER |
| R01 HL059842 | NHLBI NIH HHS | United States | R01HL059842 | PubMed and NIH | NIH RePORTER |
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22988248 | Versatile high resolution oligosaccharide microarrays for plant glycobiology and cell wall research. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22988248 | PubMed |
| 2 | 26561965 | Carbohydrate-Aromatic Interactions in Proteins. | J Am Chem Soc | 2015 | https://conductscience.org/library/papers/26561965 | PubMed |
| 3 | 33045718 | SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. | Nature | 2020 | https://conductscience.org/library/papers/33045718 | PubMed |
| 4 | 9488395 | Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. | Infect Immun | 1998 | https://conductscience.org/library/papers/9488395 | PubMed |
| 5 | 14985706 | HIV vaccine design and the neutralizing antibody problem. | Nat Immunol | 2004 | https://conductscience.org/library/papers/14985706 | PubMed |
| 6 | 10816523 | Antibody interactions with the capsule of Cryptococcus neoformans. | Infect Immun | 2000 | https://conductscience.org/library/papers/10816523 | PubMed |
| 7 | 19324053 | Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains. | J Mol Biol | 2009 | https://conductscience.org/library/papers/19324053 | PubMed |
| 8 | 8432823 | Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. | J Clin Microbiol | 1993 | https://conductscience.org/library/papers/8432823 | PubMed |
| 9 | 22390135 | Construction of a natural mucin microarray and interrogation for biologically relevant glyco-epitopes. | Anal Chem | 2012 | https://conductscience.org/library/papers/22390135 | PubMed |
| 10 | 33822048 | Population genomic analysis of Cryptococcus Brazilian isolates reveals an African type subclade distribution. | G3 (Bethesda) | 2021 | https://conductscience.org/library/papers/33822048 | PubMed |
| 11 | 36634695 | WHO publish fungal priority pathogens list. | Lancet Microbe | 2023 | https://conductscience.org/library/papers/36634695 | PubMed |
| 12 | 8459205 | Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. | J Exp Med | 1993 | https://conductscience.org/library/papers/8459205 | PubMed |
| 13 | 3512735 | Serotypes of Cryptococcus neoformans in patients with AIDS. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3512735 | PubMed |
| 14 | 18347023 | Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18347023 | PubMed |
| 15 | 28143979 | Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen. | mBio | 2017 | https://conductscience.org/library/papers/28143979 | PubMed |
| 16 | 8408031 | A revised structure for fucoidan may explain some of its biological activities. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8408031 | PubMed |
| 17 | 38330012 | The structure of a C. neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38330012 | PubMed |
| 18 | 11331716 | Serologic evidence for Cryptococcus neoformans infection in early childhood. | Pediatrics | 2001 | https://conductscience.org/library/papers/11331716 | PubMed |
| 19 | 12133962 | Isotype can affect the fine specificity of an antibody for a polysaccharide antigen. | J Immunol | 2002 | https://conductscience.org/library/papers/12133962 | PubMed |
| 20 | 1676047 | The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. | J Exp Med | 1991 | https://conductscience.org/library/papers/1676047 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42504977 | Using Synthetic Glycans to Investigate Anti-Glycan Antibodies and Explore Their Medical Potential. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42504977 | PubMed |
| 41130592 | Unexpected Variability in Laboratory and Clinical Assays Used to Quantify Cryptococcus neoformans Polysaccharide. | J Infect Dis | 2026 | https://conductscience.org/library/papers/41130592 | PubMed |
| 39601568 | The buoyancy of cryptococcal cells and its implications for transport and persistence of Cryptococcus in aqueous environments. | mSphere | 2024 | https://conductscience.org/library/papers/39601568 | PubMed |
| 38916244 | Automated Synthesis of Algal Fucoidan Oligosaccharides. | J Am Chem Soc | 2024 | https://conductscience.org/library/papers/38916244 | PubMed |
| 38819951 | Semisynthetic Glycoconjugate Vaccine Candidates against Cryptococcus neoformans. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/38819951 | PubMed |
| 38763332 | Immunoglobulin constant regions provide stabilization to the paratope and enforce epitope specificity. | J Biol Chem | 2024 | https://conductscience.org/library/papers/38763332 | PubMed |
| 38335259 | A consensus structural motif for the capsular polysaccharide of Cryptococcus Neoformans by NMR/MD. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38335259 | PubMed |
| 38330012 | The structure of a C. neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38330012 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37856427
GET https://conductscience.org/api/papers/v1/37856427/references?page=2